Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Enablence Technologies Secures CA$25 Million Investment from Collingwood

Enablence Technologies Secures CA$25 Million Investment from Collingwood

MT newswireMT newswire2026/09/15 13:39
09:39 AM EDT, 09/15/2026 (MT Newswires) -- Enablence Technologies (ENA.V) has secured an equity investment of CA$25 million from Collingwood Investments. Under the offering, Enablence will issue 3.23-million shares priced at CA$7.75 each, a 21% premium to their Sept.14 closing price, the company said Tuesday. The investment will give Collingwood a 13.3% stake in Enablance. It previously held no shares in the company. The optical-technologies company plans to use proceeds to expand capacity at its facilities in Silicon Valley and Vietnam, to support growing sales volumes and for general corporate purposes. "The capital will enable us to accelerate our expansion plans and strengthen our competitive position in the rapidly evolving photonics market," Chief Executive Officer Todd Haugen said. Enablence shares last traded Monday, closing at CA$6.39 on the TSX Venture Exchange.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

siRNA rising star ADARx (ADRX.US) launches $350 millions IPO, AbbVie subscribes to 4.9% of shares with a maximum investment of $100 millions

ADARx plans to raise $350 millions and list on Nasdaq. AbbVie will invest up to $100 millions to acquire a 4.9% stake, with a median valuation of $1.8 billions.

智通财经2026/09/22 07:21

Roche (RHHBY.US) weight loss injection shows positive mid-term trial results: average weight loss of 15.5% over 48 weeks, blood sugar levels drop by 2.65%.

The experimental weight-loss injection enicepatide simultaneously lowered blood sugar and body weight in overweight or obese patients with type 2 diabetes during a mid-stage clinical trial.

智通财经2026/09/22 07:11

SPAC company Silicon Valley Acquisition II (SVATU.US) applies for US stock IPO, aiming to raise up to 220 millions USD.

The blank-check company (SPAC) Silicon Valley Acquisition II submitted a filing to the U.S. Securities and Exchange Commission (SEC) on Monday, planning to raise up to 220 millions USD through an initial public offering (IPO).

智通财经2026/09/22 07:11